Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

February 21, 2017 at 3:25 pm

Journal of Clinical Microbiology February 2016 V.54 N.2 P.265-273

Minireviews

Gavin Cloherty, Andrew Talal, Kelly Coller, Corklin Steinhart, John Hackett Jr., George Dawson, Juergen Rockstroh, and Jordan Feld

aAbbott Diagnostics, Abbott Park, Illinois, USA

bUniversity at Buffalo, Buffalo, New York, USA

cViiV Healthcare, Research Triangle Park, North Carolina, USA

dUniversity Bonn, Bonn, Germany

eUniversity of Toronto, Toronto, Canada

The drugs available for the treatment of hepatitis C virus (HCV) have evolved to provide shorter treatment duration and higher rates of sustained virologic response (SVR), and the role of HCV infection diagnostic tests has had to evolve in order to meet changing clinical needs. This review gives an overview on the role of HCV infection diagnostic testing (molecular and serological tools) used in the diagnosis and management of HCV infection. All of this critical information guides physician decisions to optimize patient clinical outcomes. Also discussed is the future direction of diagnostic testing in the context of further advances in drug development.

PDF

http://jcm.asm.org/content/54/2/265.full.pdf

Advertisements

Entry filed under: Biología Molecular, Epidemiología, Hepatitis C, Infecciones virales, Metodos diagnosticos, REVIEWS, Update.

Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis Unveiling New Aspects of Meningococcal Carriage and Disease Prevention


Calendar

February 2017
M T W T F S S
« Jan   Mar »
 12345
6789101112
13141516171819
20212223242526
2728  

Most Recent Posts


%d bloggers like this: